Access the full text.
Sign up today, get DeepDyve free for 14 days.
Rittmaster (1990)
1096J Clin Endocrinol Metab., 70
E. Baulieu, P. Mauvais‐Jarvis (1964)
Studies on testosterone metabolism, II, 239
E. Moghissi, F. Ablan, R. Horton (1984)
Origin of plasma androstanediol glucuronide in men.The Journal of clinical endocrinology and metabolism, 59 3
Imperato-McGinley (1982)
931J Clin Endocrinol Metab., 54
T. Ito, R. Horton (1971)
The source of plasma dihydrotestosterone in man.The Journal of clinical investigation, 50 8
Horton (1982)
1203J Clin Invest., 69
P. Rao, J. Burdett, P. Moore, R. Horton (1987)
Isolation and identification of androstanediol glucuronide from human plasma.Journal of steroid biochemistry, 28 5
C. Longcope, T. Kato, R. Horton (1969)
Conversion of blood androgens to estrogens in normal adult men and women.The Journal of clinical investigation, 48 12
JA Mahoudeau, CW Bardin, M. Lipsett (1971)
The metabolic clearance rate and origin of plasma dihydrotestosterone in man and its conversion to 5α androstanediol, 50
R. Paulson, P. Serafini, J. Catalino (1986)
Measurements of 3α 7β Androstanediol glucuronide in serum and urine and the correlation with skin 5α reductase activity, 46
R. Rittmaster, D. Thompson (1990)
Effect of Leuprolide and Dexamethasone on hair growth in hirsute women, 70
D. Lookingbill, N. Egan, R. Santen, L. Demers (1988)
Correlation of Serum 3α-Androstanediol Glucuronide with Acne and Chest Hair Density in MenThe Journal of Clinical Endocrinology and Metabolism, 67
V. Toscano, R. Horton (1987)
Circulating dihydrotestosterone may not reflect peripheral formation.The Journal of clinical investigation, 79 6
Lobo (1983)
393J Clin Endocrinol Metab., 57
R. Horton, J. Tait (1966)
Androstenedione production and interconversion rates measured in peripheral blood and studies on the possible site of its conversion to testosterone.The Journal of clinical investigation, 45 3
Reiner (1989)
105J Clin Endocrinol Metab., 69
Alain Bélanger, Michéle Brochu, Jacques Clich (1986)
Plasma levels of steroid glucuronides in prepubertal, adult and elderly men.Journal of steroid biochemistry, 24 5
T. Kinouchi, R. Horton (1974)
3α-Androstanediol Kinetics in ManJournal of Clinical Investigation, 54
Kuttenn (1977)
8391J Clin Endocrinol Metab., 75
Lobo (1987)
711J Clin Endocrinol Metab., 65
Mahoudeau (1971)
1338J Clin Invest., 50
Mauvais-Jarvis (1973)
452J Clin Endocrinol Metab., 36
P. Mauvais‐Jarvis, G. Charransol, F. Bobas‐Masson (1973)
Simultaneous determination of urinary androstanediol and testosterone as an evaluation of human androgenicity, 36
T. Ishimaru, W. Edmiston, L. Pages, R. Horton (1978)
Splanchnic extraction and conversion of testosterone and dihydrotestosterone in man.The Journal of clinical endocrinology and metabolism, 46 4
I. Antonipillai, E. Moghissi, D. Hawks (1983)
The origin of plasma deoxycorticosterone in men and women during the menstrual cycle, 56
Paulson (1986)
222Fertil Steril., 46
J. Wilson (1972)
Recent studies on the mechanism of action of testosterone.The New England journal of medicine, 287 25
R. Horton, D. Hawks, R. Lobo (1982)
3α1 17β androstanediol glucuronide in plasma, 69
Baulieu (1964)
1578J Biol Chem., 239
Horton (1983)
261, 11
N. Ertel, S. Akgum, E. Samojlik (1989)
Decreased 3 alpha androstanediol glucuronide levels in plasma and urine in male pseudohermaphroditism caused by 5α reductase deficiency, 38
T. Ito, Richard Horton (1970)
Dihydrotestosterone in human peripheral plasma.The Journal of clinical endocrinology and metabolism, 31 4
R. Horton (1983)
Serono Symposium, 11
Ertel (1989)
817Metabolism., 38
J. Imperato‐McGinley, R. Peterson, T. Gautier (1982)
Hormonal evaluation of a large kindred with complete androgen insensitivity, 54
R. Lobo, U. Goebelsmann, R. Horton (1983)
Evidence for the importance of peripheral events in the development of hirsutism in polycystic ovary syndrome, 57
L. Riddick, L. Garibaldi, Michelle Wang, A. Senne, P. Klimah, A. Clark, L. Levine, S. Oberfield, S. Pang (1991)
3α-Androstanediol Glucuronide in Premature and Normal PubarcheThe Journal of Clinical Endocrinology and Metabolism, 72
Giapulli (1989)
935J Steroid Biochem., 33
B. Reiner, P. Donohue, C. Migeon (1989)
Serum 3α androstanediol glucuronide measurements in sexually mature women with congenital adrenal hyperplasia during therapy, 69
I. Antonipillai, E. Moghissi, D. Hawks, T. Schneider, R. Horton (1983)
Physiological Concentrations of Growth Hormone Exert Insulin-Like and Insulin Antagonistic Effects on Both Hepatic and Extrahepatic Tissues in Man*The Journal of Clinical Endocrinology and Metabolism, 56
F. Kuttenn, I. Mowszowicz, G. Schaison, P. Mauvais‐Jarvis (1977)
Androgen production and skin metabolism in hirsutism.The Journal of endocrinology, 75 1
V. Giapulli, L. Verdonck, R. Giorgino (1989)
Precursors of plasma androstanediol glucuronides in women, 33
R. Lobo, W. Paul, E. Gentzschein (1987)
Production of 3α androstanediol glucuronide in human genital skin, 65
ABSTRACT: Androgen action in sexual tissues, especially skin and the prostate, is expressed by dihydrotestosterone (DHT) acting at the nuclear level. Dihydrotestosterone in the circulation and target tissues is almost solely derived from the peripheral conversion of secreted testosterone (T) in men and androstenedione in women. The general pathway is testosterone → DHT → androstanediol (3α diol). However, a number of studies suggest that blood DHT or 3α diol are not reliable indicators of peripheral DHT formation. This is particularly suggested by discrepancies in the specific activity of DHT in blood and urine following infusion of labeled DHT, suggesting that total body DHT formation is not reflected by blood levels. Thus, DHT should be thought of as a paracrine hormone formed and acting primarily in target tissues. 3α androstanediol glucuronide (3α diol G) is a major metabolite of DHT. An important site of its formation is the skin. Levels in blood and urine are increased in hirsutism and acne, and blood levels closely parallel pubertal development. 3α diol G levels are especially increased in adrenal disorders of androgenicity such as andrenogenital syndrome; it is also a good marker of response to therapy. Levels are reduced in various forms of male pseudohermaphroditism. 3α androstanediol glucuronide appears to be the best marker available of DHT formation in target tissues such as skin.
Journal of Andrology – Wiley
Published: Feb 2, 1992
Keywords: ; ; ; ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.